Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra net income
Net income is the profit left for shareholders after every expense, interest and tax.
Neutra's net income for the twelve months ending Oct 31, 2023 was -$473.83K. For fiscal 2023 it was -$561.42K. The highest annual figure on record is -$81.22K in fiscal 2012.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | -$561.42K | – |
| FY2022 | Jan 31, 2022 | -$632.93K | – |
| FY2021 | Jan 31, 2021 | -$538.89K | – |
| FY2020 | Jan 31, 2020 | -$695.62K | – |
| FY2019 | Jan 31, 2019 | -$2.43M | – |
| FY2018 | Jan 31, 2018 | -$519.03K | – |
| FY2017 | Jan 31, 2017 | -$867.88K | – |
| FY2016 | Jan 31, 2016 | -$1.44M | – |
| FY2015 | Jan 31, 2015 | -$1.90M | – |
| FY2014 | Jan 31, 2014 | -$1.26M | – |
| FY2013 | Jan 31, 2013 | -$365.75K | – |
| FY2012 | Jan 31, 2012 | -$81.22K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$54.99K | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$71.85K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$72.00K | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$275.00K | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$81.79K | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$97.43K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$107.20K | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$175.77K | – |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | -$178.95K | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$140.88K | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$137.32K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$246.89K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$109.32K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$72.30K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$110.37K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$210.55K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$219.06K | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$137.80K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$128.21K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$445.72K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$1.71M | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$138.47K | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$131.84K | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | -$100.46K | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$54.43K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$154.13K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$210.01K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | -$353.33K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | -$166.30K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | -$164.92K | – |
| Q1 FY2017CQ1 2016 | Apr 30, 2016 | -$183.34K | – |
| Q4 FY2016CQ4 2015 | Jan 31, 2016 | -$647.72K | – |
| Q3 FY2016CQ3 2015 | Oct 31, 2015 | -$240.49K | – |
| Q2 FY2016CQ2 2015 | Jul 31, 2015 | -$195.33K | – |
| Q1 FY2016CQ1 2015 | Apr 30, 2015 | -$359.10K | – |
| Q4 FY2015CQ4 2014 | Jan 31, 2015 | -$476.69K | – |
| Q3 FY2015CQ3 2014 | Oct 31, 2014 | -$531.84K | – |
| Q2 FY2015CQ2 2014 | Jul 31, 2014 | -$527.98K | – |
| Q1 FY2015CQ1 2014 | Apr 30, 2014 | -$360.31K | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | -$412.63K | – |
See a number that looks wrong?